A 56-year-old woman presents with a history of intermittent shoulder pain for the past six months. Early signs point to bursitis, but the plot thickens: She also has sarcoidosis and lymphoma. How would you proceed?
Elderly patients with late-onset rheumatoid arthritis (RA) have more inflammation in their joints than younger RA patients, even though their overall clinical disease activity (as measured by composite scores such as the Simplified Disease Activity Index or SDAI) does not appear different.
A small sham-controlled trial has shown significant differences in pain processing among fibromyalgia patients who used an FDA-approved device for at-home cranial electrical stimulation. It is evidently the first study to use fMRI to test the concept.
Among presentations on OA at last month’s American College of Rheumatology meeting, several described ways of identifying or predicting disease status and progression—through imaging, clinical features, and biochemical markers.
(VIDEO) Ultrasound can trump the DAS28 in judging the equation between rheumatoid arthritis symptoms and joint signs when making treatment decisions. James Dale MD describes his study reported at the American College of Rheumatology meeting.
Relatively inexpensive, safe, and effective, musculoskeletal ultrasound has been widely accepted in rheumatology without evidence for its benefits. A review panel for the American College of Rheumatology has issued evidence-based recommendations, which will be discussed in detail next week at its annual conference in Washington DC.